![]() |
|
|
Vol. 297, Issue 1, 316-325, April 2001
Department of Neuropharmacology, The Scripps Research Institute, La
Jolla, California
A discrete-trial current-threshold self-stimulation procedure was used
to assess the effects of increased and decreased serotonergic neurotransmission, and 5-HT1A receptor activation on brain
stimulation reward. Systemic administration of the 5-HT1A
receptor agonist 8-OH-DPAT had a biphasic effect on brain reward
thresholds, without affecting the latency to respond, a measure of
performance. The low dose of 8-OH-DPAT (0.03 mg/kg) lowered reward
thresholds, whereas higher doses (0.1 and 0.3 mg/kg) elevated
thresholds. The 5-HT1A receptor antagonist
p-MPPI had no effect on brain stimulation behavior, but
reversed both the 8-OH-DPAT-induced lowering and elevation of
thresholds, indicating that both of these effects of 8-OH-DPAT are
mediated through the 5-HT1A receptor. Injections of
8-OH-DPAT into the median raphé nucleus also lowered brain reward
thresholds, without affecting measures of performance, whereas
injections of 8-OH-DPAT into the dorsal raphé nucleus had
no effect. A high dose of the selective serotonin reuptake inhibitor
fluoxetine (10 mg/kg) elevated reward thresholds and responses
latencies, whereas lower doses (2.5 and 5.0 mg/kg) increased response
latencies without affecting thresholds. Furthermore, the
coadministration of a 5-HT1A antagonist,
p-MPPI, and a previously ineffective dose of fluoxetine,
a drug combination that increases serotonin levels, significantly
elevated thresholds. Thus, it is suggested here that the
reward-potentiating effects of systemically administered low doses of
8-OH-DPAT may be the result of reduced serotonergic neurotransmission,
mediated by activation of 5-HT1A somatodendritic
autoreceptors in the median, but not the dorsal, raphé nucleus.
In conclusion, the present data support the hypothesis that serotonin
exerts an inhibitory influence on reward processes.
This article has been cited by other articles:
![]() |
I. Kremer, R. Bachner-Melman, A. Reshef, L. Broude, L. Nemanov, I. Gritsenko, U. Heresco-Levy, Y. Elizur, and R. P. Ebstein Association of the Serotonin Transporter Gene With Smoking Behavior Am J Psychiatry, May 1, 2005; 162(5): 924 - 930. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. H. Baumann, M. A. Ayestas, L. G. Sharpe, D. B. Lewis, K. C. Rice, and R. B. Rothman Persistent Antagonism of Methamphetamine-Induced Dopamine Release in Rats Pretreated with GBR12909 Decanoate J. Pharmacol. Exp. Ther., June 1, 2002; 301(3): 1190 - 1197. [Abstract] [Full Text] [PDF] |
||||